$12.14
-0.24 (-1.94%)
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)
CAPS Rating:
A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

RSS Headlines
Fool UK